1163.01 USD-1.1%Healthcare
About the company
Eli Lilly discovers and manufactures prescription medicines, with a history that stretches back to 1876 in Indianapolis. The company made its name in diabetes care, from early insulin production to the incretin drugs that also treat obesity, a franchise that reshaped its growth profile. Beyond metabolic disease, Lilly runs major programs in oncology, immunology and neuroscience, including treatments for Alzheimer's disease. Heavy investment in manufacturing capacity and a deep clinical pipeline are central to how the business compounds over time.
Overall
5.9
Market Cap
—
P/E (ttm)
41.3
Analyst Target
1270.37 USD
+9.2%
Data as of 04:26 ·